| Favourites |

FAQ

General

Assigned items: 2

Paid Subscription

Assigned items: 4

Free Subscription

Assigned items: 2

News Letter

Assigned items: 2

Newsletter

BioMedReports Harvoni Approved For The Treatment Of Chronic Hepatitis C; TapImmune Provides Update on PolyStartâ„¢ Vaccine Pla... http://t.co/UoFNaJuTuD
15hreplyretweetfavorite
BioMedReports Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics: U.S. stocks turned lower in af... http://t.co/gHIHogcGHP
16hreplyretweetfavorite
BioMedReports Agios Pharma Reports Initiation of Phase 1/2 Clinical Trial of AG-221; Pluristem Advances its Second Major Cel... http://t.co/qkvJGEUaT5
navigation
Benzinga.com supporter Seeking Alpha Certified